Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-13

Clinical Trial Update: To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating drug-drug interaction and relative bioavailability between a fixed-dose combination nasal spray (Azelastine HCl/Beclometha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelastine HCl/Beclomethasone Dipropionate nasal spray (Azelastine HCl / Beclomethasone Dipropionate)
  • Beclomethasone Dipropionate nasal spray (Beclomethasone Dipropionate)
  • RinoClenil nasal spray (Beclomethasone Dipropionate)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Seasonal Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED